More programs, more candles, more light.

Get the Flash Player to see this player.

Loading the player ...

A safety, Tolerability, and Efficacy Study of VC-01 Combination Product in Subjects with Type 1 Diabetes Mellitus

January 30, 2015
15 minutes
Kevin D'Amour, Robert Henry


Kevin D'Amour:


VP, Research & Chief Scientific Officer, ViaCyte.


Robert Henry:


Professor of Medicine, UC San Diego.


Chief, Section of Endocrinology, Metabolism & Diabetes, VA San Diego Healthcare System.